维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="CHAPLIN D J"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The influence of tumour temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies 显示文摘	Chaplin D J Horsman MR	1994	Radiother Oncol1994，30，：	1
2	The susceptibili- ty of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability 显示文摘	Beauregard DA Hill SA Chaplin D J Brindle KM	2001	Cancer Res2001，61，18：	1
3	Influence of the homozygous mosaic-resistance factor on quantitative characters offule-curedtobacco显示文摘	Chaplin J F Matzinger D F Mann T J	1996	Tob Sic1996，10，：	1
4	Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents 显示文摘	CHAPLIN D J PETTIT G R PARKINS C S	1996	Br J Cancer1996，27，2：	1
5	Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo 显示文摘	GALBRAITH S M CHAPLIN D J LEE F	2001	Anticancer Res2001，，：	1
6	A review and update of the current status of the vasculaturedisabling agent combretastatin-A4 phosphate(CA4P)显示文摘	SIEMA D W Chaplin D J Patricia A W	2009	Expert Opin Investig Drugs2009，18，2：	1
7	Tumour vasculature as a target for cancer therapy显示文摘	CHAPLIN D J DOUGHERTY G J	1999	Br J Cancer1999，80，1：	1
8	Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate显示文摘	Chaplin D J Pettit GR Hill SA	1999	Anticancer Res1999，19，1：	1
9	Science显示文摘	Kong J Franklin N R Chongwu Z Chapline M G Peng S Dyeongjae C Hongjie D	2000	287: 622-6252000，287，：	1
10	Vascular-targeting therapies for treatment of malignant disease 显示文摘	Siemann D W Chaplin D J Horsman M R	2004	Cancer2004，100，12：	1
11	Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells显示文摘	WERLING D HOPE J C CHAPLIN P	1999	Journal of Leuko- cyte Biology1999，66，1：	1
12	A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P) 显示文摘	Siemann D W Chaplin D J Walicke P A	2009	Expert Opin Investig Drugs2009，18，2：	1
13	The development of combretastatin A4 phosphate as a vascular targeting agent显示文摘	CHAPLIN D J HILL S A	2002	Int J Radia Oncol Biol Phys2002，54，5：	1
14	Nitrilase-catalysed desymmetrisation of 3-hydroxyglutaronitrile:Preparation of a statin side-chain intermediate显示文摘	Bergeron S Chaplin D A Edwards J H	2006	Org Process Res Dev2006，10，3：	1
15	Combretastatin A-4,an agent that displays potent and selective toxicity toward tumor vasculature显示文摘	Dark G G Hill S A Prise V E Tozer G M Pettit G R Chaplin D J	1997	Cancer Res1997，57，：	1
16	Compressibility of CaZrO3 per- ovskite :comparison with Ca-oxide perovskites 显示文摘	Ross N L Chaplin J T D	2003	Journal ofSolid State Chemistry2003，172，：	1
17	The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability 显示文摘	Beauregard D A Hill S A Chaplin D J Brindle K M	2001	Cancer Res2001，61，：	1
18	The first international conference on vascular targeting: meeting overview显示文摘	THORPE PE CHAPLIN D J BLAKEY DC	2003	Cancer Res2003，63，5：	1
19	Vascular-targeting therapies for treatment of malignant disease显示文摘	Siemann D W Chaplin D J Horsman M R	2004	Cancer2004，100，12：	1
20	A review and update of the current status of the vaseulature-dis- abling agent combretastatin-A4 phos- phate (CA4P) 显示文摘	Siemann DW Chaplin D J Wal- icke PA	2009	Expert Opin Investig Drugs2009，18，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示